When creating groundbreaking health care technology, keeping products user friendly is a necessity. Photo via Getty Images

In the vibrant landscape of startups, the quest to build groundbreaking products can sometimes overshadow the true essence of our existence — to solve problems for our customers.

It's a trap many fall into, often leading to two common outcomes: prolonged product launches stretching over years or an unfortunate mismatch between product and market leading to startup death. But a dynamic solution exists, minimum viable products, or MVPs. MVP has propelled startups to unprecedented success.

A real-life testimony: MVP's power

Imagine a health care-focused at-home testing startup partnered with a major player. The aim: a telehealth support system for the at-home colon cancer screening. Unlike traditional telehealth services, this system required guiding members through a complex process of collecting stool samples accurately.

Challenges presented

  • Develop a user-friendly telehealth solution in five to six weeks on a limited budget and secure a high-stakes multimillion-dollar deal.
  • Carefully integrating telehealth on the existing portal for user-friendly access while aligning seamlessly with user expectations.
  • Address the complexities of Telehealth, including clinician staffing and regulatory adherence.

User Insights

User journeys and interviews confirmed the necessity for guided support during test-taking, but users showed reluctance to navigate the process independently and expressed a preference for customer support over a clinician assistant.

Interestingly, telehealth was not instinctively linked to test support, but rather to medical advice.

The birth of an MVP strategy: a catalyst for innovation

Since the main user problem was the guided support during test-taking, we created the following MVP solutions.

  • Video call integration: Direct video call button under customer support.
  • Guided messaging: Articulate call support purpose.
  • Testing guides: Portal's step-by-step guidance with videos.
  • Video guide in test kit materials.

Our MVP led us to an excellent NPS score and became a guide for our future roadmap.

Next time you build, remember this and embrace the dynamic MVP strategy — create, learn, and reiterate are the cornerstones of success in digital health product management's journey.

Here are four steps for building a successful MVP in telehealth.

  • Identify crucial user problems: Pinpoint your target customers' most pressing issue.
  • Solve a small problem simply: Initiate a straightforward solution to address a minor problem.
  • Plot the user's journey: Map out the user's path through your solution.
  • Prioritize ruthlessly: Discern the key features and prioritize with precision.
------

Tanu Jain is the founder and CEO of Houston-based Digital Health Innovator, a strategic marketing firm for health care products.

This Houston expert describes the main phases central to any innovation journey. Photo courtesy of Slalom

Houston expert: How to navigate the innovation journey — from PoC to MVP

guest column

As a technologist, one thing I learned early in my career about the technology landscape is its constant improvements and I understood that companies who kept up with those changes remain successful and competitive. However, only companies mastering a disciplined innovation framework are truly able to harness the power of emerging tech to help them solve their most complex business challenges.

Innovative solutions come in all shapes and sizes, but not all of them should come to life. Specifically, when considering digital solutions, there are a few widely accepted innovation approaches in the product engineering field. This quick guide describes the main phases central to any innovation journey.

Feasibility Study

Ideating can be fun but executing a feasibility study will ground you on what will work and what may still be science fiction. The thought here is to spend two to four weeks doing research and talking to experts to answer a few key questions that will help you determine the feasibility of your idea or concept. Through the study, you will learn how to look at it from both a technology and a business perspective. More importantly, to answer the question 'Is it even possible to accomplish your goal with this technology?'

A subject matter expert (SME) will quickly tell you yes or no and why. If you find the technology is indeed suitable, then you will move on to evaluate the business feasibility. Does it make financial sense? Does it work within established business policies? Will there be a healthy Return On Investment (ROI) within an acceptable timeline? If you find positive responses to those questions, then you should feel confident to move on to a Proof of Concept (PoC) or even jump to a Minimum Viable Product (MVP). On the other hand, if either the technology is not feasible or the solution doesn't make business sense, then you've just saved yourself a lot of time, budget, and possibly headaches.

Proof of Concept

This phase is about testing the theory and proving the hypothesis, technically speaking. You'll need to go through a Proof of Concept if the technology solution you have in mind hasn't been tested in either a lab setting or in the field. Thinking outside of the box and innovating is all about trying new approaches and solving problems in a novel way, so you'll have to spend the time and budget ensuring it will work as expected. However, you must be very careful to not get carried away.

A proper PoC should take four to six weeks, max. It should help you quickly determine whether the technology will live up to its promise or if you need to pivot to another approach. Building a team with the right skillset is vital to this process because they are the ones evaluating the proposed solution and comparing it to the expected outcomes. Any signs of discord should empower the team to stop the project, saving further investment, and should help you decide if another approach is even possible. If all criteria has been met, then move on to the MVP stage.

Minimum Viable Product

At this point, you have confirmed the solution you imagined works and you are ready to unlock its potential. But you must start small. You must prioritize all the features you want this product to have and decide what the core functionality should be. This is important because if you choose too many features to start with, you may initially spend too much money and time and may even miss a window of business opportunity you may have lined up. Hence the name of the MVP, it is a product that employs the minimum time, money, and features while still being a viable product.

In summary, if you have an innovative idea for a technology solution, I recommend you first determine whether it's feasible, both technology and business wise, through a short and focused study. If feasible, then you can put that concept to the test through a PoC and determine its desirability. If this product is indeed desirable, then moving into building an MVP will help you understand its viability – and that is how you can successfully innovate while keeping risks at bay.


------

Alfredo Arvide is the director for the products and innovation practice at Slalom Consulting in Houston, where he helps clients solve their most complex business challenges by leveraging emerging technologies and applying innovative technology solutions.

A Houston startup is making it easier to connect and manage the relationship between tech freelancers and businesses with software projects. Image via Pexels

This Houston startup is changing the way companies access tech talent

freelancers unite

With the gig economy continuing to grow — especially in light of the COVID-19-caused crisis and growing unemployment — a Houston startup has created a portal for companies to access technology-focused freelancers.

FreelancingTeams, co-founded by Raj Kal, allows companies to easily search and find tech professionals for projects — as well as manage that team throughout the work. On the other side of the table, the startup is allowing the country's growing population of freelancers a platform to get picked up for jobs.

"We are changing the way we look at team building," Kal says, noting that a huge percentage of freelancers struggle to find jobs with existing resources.

Not only does FreelancingTeams act as a marketplace for tech talent, but Kal says the platform allows for project management and payment processes. While there are other talent portals — like Fiverr and Upwork — this added capability sets the startups apart from its competition.

"People come in with an idea, and they can do it from start to finish," Kal says, explaining that users don't have to find separate tools to find their team, manage the project, and price and pay for the work.

FreelancingTeams is free for clients to list and staff their projects, and a 10 to 15 percent cut comes out of the freelancer side. However, there is an option for clients to upgrade to a paid subscription option for larger, more complex projects that require additional hands-on management resources from FreelancingTeams.

With its free option, FreelancingTeams has seen a lot of interest from startups looking to build there minimum viable product, or MVP.

"We are working with a lot of startups as a Station Houston partner," Kal says. "We are helping them get their MVP done, so that when they come to our platform, we can work with them to understand the requirements and connect them to their teams."

Betsy Furler, founder of For All Abilities, a Houston-based software company aims to help businesses support employees with ADHD, Dyslexia, learning differences, and Autism, recently used FreelancingTeams to staff her MVP development project. She says using the platform made it easy to manage and test the work the freelancers were doing.

"FreelancingTeams helped me build my MVP quickly and inexpensively," Furler says. "Their quote was much less expensive than the others [I received] and the work was fantastic. Because of the platform, I also spent more time thinking through what features were needed and how to prioritize them, rather than just giving a developer or project manager a list to complete."

Outside of affordably building tech for startups, the coronavirus has greatly affected the workforce with unemployment at a historic high. This has led to an increased interest in freelancing.

"A lot of people are unemployed and are looking for alternative options," Kal says. "Freelancing is a place where we are seeing large growth."

He says he's also observing an increased interest in freelancers from large companies and even retailers who need to upgrade their online presence.

"The COVID situation has brought more challenges to bigger businesses, and they are looking for cost-effective solutions as well," Kal says.

Kal is looking to grow FreelancingTeams, which might include fundraising in the future, he says. For now, the company has a low overhead and uses freelancers on its own site to develop its technology.

"The next step for us is to grow bigger in Houston and then around Texas," Kal says.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”